TrialJournal of the Formosan Medical Association = Taiwan yi zhi2006

Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease.

Chao-Hung Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.